NO167802C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.Info
- Publication number
- NO167802C NO167802C NO885435A NO885435A NO167802C NO 167802 C NO167802 C NO 167802C NO 885435 A NO885435 A NO 885435A NO 885435 A NO885435 A NO 885435A NO 167802 C NO167802 C NO 167802C
- Authority
- NO
- Norway
- Prior art keywords
- benzotiazepine
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8717044A FR2624117B1 (fr) | 1987-12-08 | 1987-12-08 | Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique |
Publications (4)
Publication Number | Publication Date |
---|---|
NO885435D0 NO885435D0 (no) | 1988-12-07 |
NO885435L NO885435L (no) | 1989-06-09 |
NO167802B NO167802B (no) | 1991-09-02 |
NO167802C true NO167802C (no) | 1991-12-11 |
Family
ID=9357609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO885435A NO167802C (no) | 1987-12-08 | 1988-12-07 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP0320362A1 (hu) |
JP (2) | JPH01190632A (hu) |
KR (1) | KR890009901A (hu) |
AU (1) | AU609681B2 (hu) |
DK (1) | DK681088A (hu) |
FI (1) | FI885670A (hu) |
FR (1) | FR2624117B1 (hu) |
HU (1) | HU201538B (hu) |
IL (1) | IL88608A0 (hu) |
NO (1) | NO167802C (hu) |
NZ (1) | NZ227235A (hu) |
PT (1) | PT89182A (hu) |
ZA (1) | ZA889169B (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2630109B1 (fr) * | 1988-04-19 | 1991-11-29 | Synthelabo | Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique |
US4963545A (en) * | 1988-05-24 | 1990-10-16 | Marion Laboratories, Inc. | Benzothiazepine anti-seizure method |
US5134139A (en) * | 1989-08-31 | 1992-07-28 | Tanabe Seiyaku Co., Ltd. | 1,5-benzothiazepine derivatives and preparation thereof |
FR2653122B1 (fr) * | 1989-10-17 | 1994-04-15 | Synthelabo | Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique. |
CA2030160A1 (en) * | 1989-11-22 | 1991-05-23 | Nahed K. Ahmed | Benzothiazepine metastasis treatment |
CA2030159A1 (en) * | 1989-11-22 | 1991-05-23 | Nahed K. Ahmed | Anti-cancer drug potentiators |
FR2670785B1 (fr) * | 1990-12-20 | 1993-07-09 | Synthelabo | Derives de (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique. |
ES2118292T3 (es) * | 1994-09-16 | 1998-09-16 | Orion Corp Fermion | Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3119874A1 (de) * | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
US4585768A (en) * | 1984-04-10 | 1986-04-29 | Tanabe Seiyaku Co., Ltd. | 1,5-benzothiazepine derivatives and processes for preparing the same |
US4594342A (en) * | 1984-04-10 | 1986-06-10 | Tanabe Seiyaku Co., Ltd. | 1,5-benzothiazepine derivative |
US4729994A (en) * | 1986-08-20 | 1988-03-08 | Mcneilab, Inc. | Benzothiazepine vasodilators having aralkyl substitution |
ATE64925T1 (de) * | 1986-08-20 | 1991-07-15 | Mcneilab Inc | Benzothiazepin-vasodilatoren mit aralkylsubstitution. |
FR2630109B1 (fr) * | 1988-04-19 | 1991-11-29 | Synthelabo | Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique |
-
1987
- 1987-12-08 FR FR8717044A patent/FR2624117B1/fr not_active Expired - Fee Related
-
1988
- 1988-12-06 EP EP88403079A patent/EP0320362A1/fr not_active Withdrawn
- 1988-12-06 EP EP88403078A patent/EP0320361A1/fr not_active Withdrawn
- 1988-12-06 IL IL88608A patent/IL88608A0/xx unknown
- 1988-12-07 PT PT89182A patent/PT89182A/pt not_active Application Discontinuation
- 1988-12-07 JP JP63309755A patent/JPH01190632A/ja active Pending
- 1988-12-07 AU AU26595/88A patent/AU609681B2/en not_active Ceased
- 1988-12-07 NO NO885435A patent/NO167802C/no unknown
- 1988-12-07 KR KR1019880016283A patent/KR890009901A/ko not_active Application Discontinuation
- 1988-12-07 FI FI885670A patent/FI885670A/fi not_active IP Right Cessation
- 1988-12-07 JP JP63309754A patent/JPH01190674A/ja active Pending
- 1988-12-07 ZA ZA889169A patent/ZA889169B/xx unknown
- 1988-12-07 DK DK681088A patent/DK681088A/da not_active Application Discontinuation
- 1988-12-07 NZ NZ227235A patent/NZ227235A/xx unknown
- 1988-12-07 HU HU886205A patent/HU201538B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2624117A1 (fr) | 1989-06-09 |
FR2624117B1 (fr) | 1991-02-22 |
ZA889169B (en) | 1990-05-30 |
PT89182A (pt) | 1989-12-29 |
IL88608A0 (en) | 1989-07-31 |
FI885670A (fi) | 1989-06-09 |
NZ227235A (en) | 1990-06-26 |
AU609681B2 (en) | 1991-05-02 |
JPH01190674A (ja) | 1989-07-31 |
AU2659588A (en) | 1989-06-08 |
DK681088D0 (da) | 1988-12-07 |
JPH01190632A (ja) | 1989-07-31 |
EP0320361A1 (fr) | 1989-06-14 |
NO885435D0 (no) | 1988-12-07 |
DK681088A (da) | 1989-06-09 |
KR890009901A (ko) | 1989-08-04 |
HUT50797A (en) | 1990-03-28 |
NO885435L (no) | 1989-06-09 |
NO167802B (no) | 1991-09-02 |
EP0320362A1 (fr) | 1989-06-14 |
FI885670A0 (fi) | 1988-12-07 |
HU201538B (en) | 1990-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
NO883485L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO166130C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. | |
NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO167287C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner. | |
NO891114D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
NO884175D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. |